Paediatric Crohn’s Disease Patients Have Increased Inflammatory Markers Compared to Adult Patients prior to Biological Treatment

Figure 1

Development in inflammatory markers in Crohn’s disease over time. Visit 1 at 6 weeks, visit 2 at 14 weeks, visit 3 at 22 weeks, and visit 4 at 52 weeks: (a) CRP levels (mg/L); (b) Calprotectin levels (mg/kg); (c) Albumin levels (g/L); (d) Haemoglobin levels (mmol/L); (e) Adjusted haemoglobin levels (mmol/L); (f) Vitamin D levels (mmol/l). CD: Crohn’s disease; CRP: C-reactive protein; NS: nonsignificant.

(a)

(b)

(c)

(d)

(e)

(f)